Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 60 entries
View as:

Clinical Study of R744 to Peritoneal Dialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00433849 Org: User:
Start: 02/28/07 End: 11/30/08 Due: 11/30/09

Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

Phase: N/A Priority: Normal
NCT ID: NCT00144612 Org: User:
Start: 07/31/04 End: 06/30/09 Due: 06/30/10

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Phase: N/A Priority: Normal
NCT ID: NCT06371417 Org: User:
Start: 08/19/24 End: 06/30/26 Due: 06/30/27

A Single Ascending Dose Study of PCO371 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02475616 Org: User:
Start: 06/30/15 End: 10/31/15 Due: 10/31/16

Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)

Phase: N/A Priority: Normal
NCT ID: NCT04501497 Org: User:
Start: 08/21/20 End: 02/03/23 Due: 02/03/24

Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT00144521 Org: User:
Start: 02/29/04 End: 04/30/06 Due: 04/30/07

A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT02965053 Org: User:
Start: 12/31/16 End: 08/31/18 Due: 08/31/19

A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism

Phase: N/A Priority: Normal
NCT ID: NCT04209179 Org: User:
Start: 07/23/20 End: 05/25/21 Due: 05/25/22

Clinical Study of R744 to Predialysis Patients( Phase III, Comparative Study in Comparison With Epoetin Beta)

Phase: N/A Priority: Normal
NCT ID: NCT00492427 Org: User:
Start: 06/30/07 End: 11/30/08 Due: 11/30/09

Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JP

Phase: N/A Priority: Normal
NCT ID: NCT00144586 Org: User:
Start: 03/31/05 End: 06/30/09 Due: 06/30/10

A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)

Phase: N/A Priority: Normal
NCT ID: NCT03645330 Org: User:
Start: 08/15/18 End: 07/08/21 Due: 07/08/22

Trial of Pegasys® in Patients With Chronic Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT00245414 Org: User:
Start: 10/31/05 End: 07/31/10 Due: 07/31/11

Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00467012 Org: User:
Start: 04/30/07 End: 09/30/11 Due: 09/30/12

A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)

Phase: N/A Priority: Normal
NCT ID: NCT00661284 Org: User:
Start: 04/30/08 End: 05/31/10 Due: 05/31/11

Correction Study of R744 in Renal Anemia Patients on Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT00433693 Org: User:
Start: 02/28/07 End: 10/31/08 Due: 10/31/09

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00144482 Org: User:
Start: 12/31/03 End: 08/31/05 Due: 08/31/06

Switch and Maintenance Study of Intravenous Injections of R744 to Hemodialysis Patients (Phase Ⅲ Study)

Phase: N/A Priority: Normal
NCT ID: NCT00433888 Org: User:
Start: 01/31/07 End: 10/31/08 Due: 10/31/09

A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT01656525 Org: User:
Start: 06/30/12 End: 06/30/14 Due: 06/30/15

Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00144573 Org: User:
Start: 01/31/05 End: 10/31/05 Due: 10/31/06

Study of AUBE00 in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT07030959 Org: User:
Start: 06/05/25 End: 06/30/30 Due: 06/30/31

A New Active Vitamin D, ED-71 for Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT00144456 Org: User:
Start: 09/30/04 End: 10/31/08 Due: 10/31/09

A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00144495 Org: User:
Start: 02/29/04 End: 05/31/05 Due: 05/31/06

PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA)

Phase: N/A Priority: Normal
NCT ID: NCT00380601 Org: User:
Start: 05/31/06 End: 02/28/09 Due: 02/28/10

Clinical Study of R744 to Predialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00433615 Org: User:
Start: 02/28/07 End: 11/30/08 Due: 11/30/09

Study of MRA in Patients With Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT00144651 Org: User:
Start: 08/31/01 End: 06/30/09 Due: 06/30/10